Loading company…
ProTexase Therapeutics, Inc.
PrivateWon 2 federal SBIR/STTR research awards from HHS and other federal agencies.
Department of Health and Human ServicesNational Institutes of Health
- SAM UEI
- FMCMANG61MN5
- Founded
- —Source: [GOV]
- Headquarters
- Saint Louis, MissouriSource: [GOV]
- Headcount
- 2Source: [GOV]
- Stage
- Seed
- Sector
- Healthcare
$0Source: [GOV]Total raised
UndisclosedSource: [GOV]Last valuation
Overview
ProTexase Therapeutics, Inc. has been awarded 2 US Small Business Innovation Research (SBIR/STTR) contracts totalling $599,952 between 2018 and 2019. These are non-dilutive federal research grants, not equity financing. The company is based in Saint Louis, Missouri.
Funding rounds
2 rounds- SBIR Phase I award (HHS)GrantApr 2018Source: [GOV]$300K—post-money
- SBIR Phase I award (HHS)
Investors
No investors recorded yet for ProTexase Therapeutics, Inc..
Add an investorPeople
LeadershipAcquisitions
ProTexase Therapeutics, Inc. has no recorded acquisitions.
Add an acquisitionExits
Still private — no exit on record.
Record an exitDiversity investments
No diversity signals recorded yet for ProTexase Therapeutics, Inc..
Add diversity data